Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a CEO’s certification (Form 52-109F1) of the Annual Filings under Canadian NI 52-109, not the actual Annual Report, MD&A, or Audit Report. It is a mandatory regulatory certificate rather than substantive financial statements or management discussion. There is no specific category for NI 52-109 certificates, so it falls under the general Regulatory Filings category.
2026-04-01 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 certification form (Form 52-109F1) completed by the Interim CFO, certifying the annual information form, annual financial statements and annual MD&A for the fiscal year. It is a regulatory compliance submission rather than the Annual Report itself or an earnings release, management discussion, or proxy statement. It does not present financials or strategy but confirms disclosure controls per securities legislation. Thus, it falls under the fallback “Regulatory Filings” category.
2026-04-01 English
Annual information form - English.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL INFORMATION FORM' (AIF) for the period ended December 31, 2025. In Canadian securities regulation, an Annual Information Form is a disclosure document that provides material information about a company and its business, which is distinct from the financial statements themselves. Within the provided classification schema, '10-K' is the designated category for comprehensive annual reporting, which encompasses the Annual Information Form in the context of North American regulatory filings. FY 2025
2026-04-01 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a standalone CEO/management certification under National Instrument 52-109, certifying the annual filings (AIF, MD&A, financial statements) for the year ended December 31, 2025. It is not the full annual report itself (10-K), nor an independent auditor’s report (AR), MD&A, or any other specific category. It is a regulatory compliance filing that does not neatly fall into the defined specific categories, so it defaults to a general regulatory filing (RNS).
2026-04-01 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F1 Certification of Annual Filings under Canadian securities rules – a required officer certification accompanying the company’s annual financial filings. It is not the actual annual report (10-K/AR), nor a dividend, voting or capital notice, nor a management discussion or earnings release in itself. It also isn’t simply an announcement that a report has been published (so not RPA). Thus, it falls into the fallback category for miscellaneous regulatory filings: RNS.
2026-04-01 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis” and provides management’s detailed explanation of the company’s financial results, business overview, operations, liquidity, and forward‐looking statements for the years ended December 31, 2025 and 2024. It is not an earnings release (key highlights only), nor an announcement of a report – it is the MD&A itself. Therefore it best fits the “Management Reports” category (Code: MDA).
2026-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.